Confidence

Family from Mumbai, India to the INR in 2015 & May 2017

Family from Mumbai, India on their second visit to the INR, in May 2017. First visit and treatment at the INR was in November 2015, four years after her stroke. The family discusses her neurological improvement after her first treatment at the INR. Her neurological improvement increased month after month and now has been sustained for 1 1/2 years and counting.

Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. The method utilized for this indication is off-label. Please see the Terms of Use. Copyright 2017 INR PLLC, all rights reserved.

About the Institute

Over the course of more than a decade INR medical providers and their colleagues have published a series of peer-reviewed publications that have helped illuminate the role of immune mechanisms in the pathogenesis of a variety of neuroinflammatory disorders. In particular, these publications have provided new insight into the role of excess TNF in brain disorders and neuropathic pain.

Hundreds of scientific articles from academic scientists in the U.S., Canada, Europe, Asia, and Latin America have cited INR publications. In addition to patient care, the INR trains physicians in the proper implementation of its patented, off-label perispinal etanercept treatment methods. The INR physician training program has been attended by physicians from six continents.

Branding

Site Message

Mobile Header

Family from Mumbai, India to the INR in 2015 & May 2017

About the Institute

About the Institute